Fig. 7From: The past, present and future of anti-malarial medicinesKey stages in the hit to lead pathway of M5717. Initial replacement of Br for F, replacement of pyridine with ethylpyrrolidine, and addition of a morpholine fragment led to the optimized compound M5717Back to article page